Show simple item record

dc.contributor.authorIngimarsson, Johann P
dc.contributor.authorIsaksson, Helgi J
dc.contributor.authorSigbjarnarson, Hermann P
dc.contributor.authorGudmundsson, Jens
dc.contributor.authorGeirsson, Gudmundur
dc.date.accessioned2014-09-04T11:21:17Z
dc.date.available2014-09-04T11:21:17Z
dc.date.issued2014-02
dc.date.submitted2014
dc.identifier.citationScand J Urol. 2014, 48 (1):73-8en
dc.identifier.issn2168-1813
dc.identifier.pmid23924152
dc.identifier.doi10.3109/21681805.2013.825878
dc.identifier.urihttp://hdl.handle.net/2336/325873
dc.descriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the pageen
dc.description.abstractThe aim of this study was to determine whether there are correlations between medication use for lower urinary tract symptoms/benign prostate hypertrophy (LUTS/BPH) and alteration in incidence and indications for transurethral resection of the prostate (TURP).
dc.description.abstractThe number of TURP patients between 1984 and 2008 in Iceland was obtained from hospital registries. The number of defined daily doses (DDDs) of 5-alpha-reductase inhibitors (5aRIs) and alpha-blockers (ABs) sold was obtained from the Icelandic Medicines Control Agency. Charts of all surgical BPH patients in Iceland from 1998 to 2008 were retrospectively reviewed. The main outcomes measures were: DDDs sold of 5aRIs and ABs, total numbers of TURP, indications for TURP and complications.
dc.description.abstractAfter the introduction of ABs and 5aRIs, sales increased annually at a near linear rate. TURP rates peaked in 1992, then declined. In 2008, 81 and 3.4 of 1000 men over the age of 50 used LUTS/BPH medications or underwent TURP, respectively. There was an inverse correlation between LUTS/BPH medication use and (i) overall TURP (R(2) = 0.85), (ii) TURP done for absolute indications (R(2) = 0.91), and (iii) LUTS with (R(2) = 0.77) and (iv) without previous medical therapy (R(2) = 0.75). As medication use rose, fewer TURPs were performed for previous history of urinary retention, and more for recurrent urinary tract infections.
dc.description.abstractIncreased use of ABs and 5aRIs in the Icelandic population correlated with decreasing incidences of TURP procedures for both LUTS and absolute indications. The sequelae of BPH and indications for TURP are changing as medication use increases, although a clear causative link is hard to establish.
dc.description.sponsorshipIcelandic Urology Associationen
dc.language.isoenen
dc.publisherInforma Healthcareen
dc.relation.urlhttp://dx.doi.org/10.3109/21681805.2013.825878en
dc.rightsArchived with thanks to Scandinavian journal of urologyen
dc.subjectLyfjanotkunen
dc.subjectÞvagfærasjúkdómaren
dc.subjectBlöðruhálskirtillen
dc.subject.meshProstatic Hyperplasiaen
dc.subject.meshAdrenergic alpha-Antagonistsen
dc.subject.mesh5-alpha Reductase Inhibitorsen
dc.subject.meshTransurethral Resection of Prostateen
dc.subject.meshAdulten
dc.subject.meshAgeden
dc.subject.meshAged, 80 and overen
dc.subject.meshHumansen
dc.subject.meshIcelanden
dc.subject.meshLower Urinary Tract Symptomsen
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshRetrospective Studiesen
dc.subject.meshTransurethral Resection of Prostateen
dc.titleIncreased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.en
dc.typeArticleen
dc.contributor.departmentLandspitali Univ Hosp, Dept Urol, Reykjavik, Iceland, Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland, Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03766 USA, Univ Iceland, Fac Med, Reykjavik, Icelanden
dc.identifier.journalScandinavian journal of urologyen
dc.rights.accessClosed - Lokaðen
html.description.abstractThe aim of this study was to determine whether there are correlations between medication use for lower urinary tract symptoms/benign prostate hypertrophy (LUTS/BPH) and alteration in incidence and indications for transurethral resection of the prostate (TURP).
html.description.abstractThe number of TURP patients between 1984 and 2008 in Iceland was obtained from hospital registries. The number of defined daily doses (DDDs) of 5-alpha-reductase inhibitors (5aRIs) and alpha-blockers (ABs) sold was obtained from the Icelandic Medicines Control Agency. Charts of all surgical BPH patients in Iceland from 1998 to 2008 were retrospectively reviewed. The main outcomes measures were: DDDs sold of 5aRIs and ABs, total numbers of TURP, indications for TURP and complications.
html.description.abstractAfter the introduction of ABs and 5aRIs, sales increased annually at a near linear rate. TURP rates peaked in 1992, then declined. In 2008, 81 and 3.4 of 1000 men over the age of 50 used LUTS/BPH medications or underwent TURP, respectively. There was an inverse correlation between LUTS/BPH medication use and (i) overall TURP (R(2) = 0.85), (ii) TURP done for absolute indications (R(2) = 0.91), and (iii) LUTS with (R(2) = 0.77) and (iv) without previous medical therapy (R(2) = 0.75). As medication use rose, fewer TURPs were performed for previous history of urinary retention, and more for recurrent urinary tract infections.
html.description.abstractIncreased use of ABs and 5aRIs in the Icelandic population correlated with decreasing incidences of TURP procedures for both LUTS and absolute indications. The sequelae of BPH and indications for TURP are changing as medication use increases, although a clear causative link is hard to establish.


This item appears in the following Collection(s)

Show simple item record